# ADDvise Group signs LOI to acquire CliniChain Holding

ADDvise Group AB has signed a Letter of Intent to acquire 100% of CliniChain Holding B.V., a medtech equipment provider for clinical studies based in Almere, Netherlands. The purchase price is EUR 33.80 million, with completion scheduled for Q4 2022.

- Type: Acquisition
- Announced: 2022-09-06
- Where: Almere, Netherlands, Netherlands
- Value: $33.7M (33.8M EUR)
- Status: announced
- Products: medtech equipment for clinical studies
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [ADDvise Group](https://endata.com/companies/21338.md) (acquirer)
- [CliniChain Holding](https://endata.com/companies/65158.md) (target)

## Sources

- [news.cision.com](https://news.cision.com/addvise-group-ab/r/addvise-signs-letter-of-intent-to-acquire-clinichain-holding-b-v-,c3626906), 2022-09-06: "ADDvise Group AB (publ) has signed a Letter of Intent with the shareholders of CliniChain Holding B.V. regarding an acquisition of 100 percent of the shares in CliniChain."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.